Total Payments
$15,194
2024 Payments
$1,552
Companies
44
Transactions
649
Medicare Patients
10,753
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$15,156 (99.7%)
Education$38.68 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,156 | 643 | 99.7% |
| Education | $38.68 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,787 | 95 | $0 (2024) |
| Amgen Inc. | $1,437 | 47 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,028 | 67 | $0 (2024) |
| Merck Sharp & Dohme LLC | $920.36 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $905.57 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $864.56 | 32 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $810.87 | 40 | $0 (2024) |
| PFIZER INC. | $721.36 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $688.89 | 27 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $673.76 | 30 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,552 | 60 | GENZYME CORPORATION ($206.58) |
| 2023 | $2,389 | 79 | CVRx, Inc. ($383.50) |
| 2022 | $1,838 | 87 | Novartis Pharmaceuticals Corporation ($331.00) |
| 2021 | $1,502 | 78 | Novartis Pharmaceuticals Corporation ($197.53) |
| 2020 | $1,467 | 61 | Bardy Diagnostics, Inc. ($276.32) |
| 2019 | $1,940 | 95 | Amarin Pharma Inc. ($321.57) |
| 2018 | $2,755 | 107 | Amgen Inc. ($401.91) |
| 2017 | $1,752 | 82 | Novartis Pharmaceuticals Corporation ($335.91) |
All Payment Transactions
649 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Cardiovascular | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: Coronary | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.25 | General |
| 10/14/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: Medical Device | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Not Applicable | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $42.14 | General |
| Category: Transcatheter Valve Systems | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Cardiovascular | ||||||
| 07/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Coronary | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,121 | 5,574 | $1.4M | $430,007 |
| 2022 | 18 | 2,702 | 5,077 | $1.1M | $391,452 |
| 2021 | 22 | 2,539 | 4,777 | $1.2M | $379,655 |
| 2020 | 19 | 2,391 | 4,440 | $1.2M | $331,451 |
Total Patients
10,753
Total Services
19,868
Medicare Billing
$1.5M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 720 | 1,667 | $502,160 | $186,259 | 37.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 458 | 465 | $269,780 | $84,860 | 31.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 89 | 89 | $115,700 | $36,966 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 178 | 178 | $72,355 | $26,553 | 36.7% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 98 | 106 | $83,740 | $26,123 | 31.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 796 | 1,735 | $69,400 | $22,268 | 32.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 88 | 175 | $50,750 | $16,725 | 33.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 63 | 246 | $184,500 | $10,463 | 5.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 82 | 83 | $16,600 | $4,868 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 64 | $12,240 | $3,989 | 32.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 268 | 455 | $15,925 | $3,822 | 24.0% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 73 | 149 | $25,360 | $2,611 | 10.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 36 | 40 | $8,800 | $2,587 | 29.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 14 | 16 | $3,680 | $520.16 | 14.1% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 62 | 62 | $1,364 | $444.57 | 32.6% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 11 | 13 | $2,730 | $427.05 | 15.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 15 | 15 | $900.00 | $311.10 | 34.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $640.00 | $209.92 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 594 | 1,530 | $428,400 | $182,727 | 42.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 445 | 455 | $273,000 | $88,643 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 148 | 148 | $59,200 | $23,870 | 40.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 51 | 51 | $69,870 | $23,200 | 33.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 653 | 1,622 | $64,880 | $22,002 | 33.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 51 | 98 | $14,700 | $9,738 | 66.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 109 | $20,710 | $9,550 | 46.1% |
About Dr. Elena Bezoff, D.O
Dr. Elena Bezoff, D.O is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417141532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elena Bezoff, D.O has received a total of $15,194 in payments from pharmaceutical and medical device companies, with $1,552 received in 2024. These payments were reported across 649 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($15,156).
As a Medicare-enrolled provider, Bezoff has provided services to 10,753 Medicare beneficiaries, totaling 19,868 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 08/31/2007
- Last Updated 09/09/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417141532
Products in Payments
- ELIQUIS (Drug) $1,459
- Repatha (Biological) $1,367
- ENTRESTO (Drug) $1,154
- VERQUVO (Drug) $884.97
- Vascepa (Drug) $688.89
- XARELTO (Drug) $673.76
- LEQVIO (Drug) $632.51
- MULTAQ (Drug) $562.73
- DUPIXENT (Biological) $520.50
- FARXIGA (Drug) $478.83
- Barostim Neo System (Device) $472.73
- JARDIANCE (Drug) $370.42
- NUCALA (Biological) $327.67
- Carnation Ambulatory Monitor (Device) $327.15
- PRALUENT (Drug) $301.83
- PRALUENT (Biological) $283.66
- NORTHERA (Drug) $263.66
- PRADAXA (Drug) $260.81
- LifeVest (Device) $234.98
- ZIO Patch (Device) $210.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799